Literature DB >> 9763085

Efficacy of one dose fluoroquinolone before prostate biopsy.

K C Shandera1, G P Thibault, G E Deshon.   

Abstract

OBJECTIVES: To demonstrate the efficacy of a simple preparation for prostate biopsy (PBX) and to determine its potential cost savings.
METHODS: One hundred fifty consecutive PBXs were performed using a Fleet enema and a single oral dose (300 mg) of ofloxacin as the pre-PBX preparation.
RESULTS: Of the 150 PBXs we performed, only 1 (0.67%) patient developed a urinary tract infection.
CONCLUSIONS: A simple and inexpensive pre-PBX preparation proved to be successful in preventing infectious complications and is presented as a potential model for inclusion in clinical pathways for diagnosing adenocarcinoma of the prostate.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9763085     DOI: 10.1016/s0090-4295(98)00311-2

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  4 in total

1.  Time of administration of a single dose of oral levofloxacin and its effect in infectious complications from transrectal prostate biopsy.

Authors:  Athanasios N Argyropoulos; Konstantinos Doumas; Antonios Farmakis; Ioannis Liakatas; Ioannis Gkialas; Michael Lykourinas
Journal:  Int Urol Nephrol       Date:  2007-01-04       Impact factor: 2.370

2.  A questionnaire survey of patient preparation and techniques for prostate biopsy among urologists in the Kyushu and Okinawa regions of Japan.

Authors:  Masanori Noguchi; Kei Matsuoka; Hirofumi Koga; Hiroshi Kanetake; Masayuki Nakagawa; Seiji Naito
Journal:  Int J Clin Oncol       Date:  2006-10       Impact factor: 3.402

3.  The efficacy of duration of prophylactic antibiotics in transrectal ultrasound guided prostate biopsy.

Authors:  Volkan Bulut; Ali Feyzullah Şahin; Yavuz Balaban; Muammer Altok; Rauf Taner Divrik; Ferruh Zorlu
Journal:  Int Braz J Urol       Date:  2015 Sep-Oct       Impact factor: 1.541

Review 4.  Surgical Antibiotic Prophylaxis in an Era of Antibiotic Resistance: Common Resistant Bacteria and Wider Considerations for Practice.

Authors:  Bradley D Menz; Esmita Charani; David L Gordon; Andrew J M Leather; S Ramani Moonesinghe; Cameron J Phillips
Journal:  Infect Drug Resist       Date:  2021-12-07       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.